CHEK1 and malignant colon neoplasm: We engrafted three colon cancer cell lines (LS-1034, SW837 and SNU-81) in NOD/SCID mice and treated them for 24–35 days with irinotecan (TOP1 inhibitor), rabusertib (CHEK1 inhibitor), or with a combination of the two drugs.